The introduction of next-generation sequencing (NGS) in the field of cancer research has boosted worldwide efforts of genome-wide personalized oncology aiming at identifying predictive biomarkers and novel actionable targets. Despite considerable progress in understanding the molecular biology of distinct cancer entities by the use of this revolutionary technology and despite contemporaneous innovations in drug development, translation of NGS findings into improved concepts for cancer treatment remains a challenge. The aim of this article is to describe shortly the NGS platforms for DNA sequencing and in more detail key achievements and unresolved hurdles. A special focus will be given on potential clinical applications of this innovative technique in the field of radiation oncology.
机构:
George Washington Univ, Med Ctr, Dept Med, Div Genom Med, Washington, DC 20037 USAGeorge Washington Univ, Med Ctr, Dept Med, Div Genom Med, Washington, DC 20037 USA
Toma, Ian
St Laurent, Georges, III
论文数: 0引用数: 0
h-index: 0
机构:
Univ Antioquia, Immunovirol Biogenesis Grp, Medellin 1226, Colombia
St Laurent Inst, Cambridge, MA USAGeorge Washington Univ, Med Ctr, Dept Med, Div Genom Med, Washington, DC 20037 USA
St Laurent, Georges, III
McCaffrey, Timothy A.
论文数: 0引用数: 0
h-index: 0
机构:
George Washington Univ, Med Ctr, Dept Med, Div Genom Med, Washington, DC 20037 USAGeorge Washington Univ, Med Ctr, Dept Med, Div Genom Med, Washington, DC 20037 USA
机构:
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, SwedenKarolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
Ku, Chee-Seng
Roukos, Dimitrios H.
论文数: 0引用数: 0
h-index: 0
机构:
Med Ctr CBS GenNetMed Ioannina Univ, Ctr Biosyst & Synthet Genom Network, Ioannina, GreeceKarolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden